Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 GBX | 0.00% | -10.00% | -20.53% |
May. 16 | Proteome Sciences promises AGM return to growth in 2024 | AN |
May. 16 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
Sales 2022 | 7.78M 9.87M | Sales 2023 | 5.03M 6.38M | Capitalization | 13.37M 16.97M |
---|---|---|---|---|---|
Net income 2022 | 1M 1.27M | Net income 2023 | -2M -2.54M | EV / Sales 2022 | 2.35 x |
Net Debt 2022 | 7.92M 10.05M | Net Debt 2023 | 11.45M 14.52M | EV / Sales 2023 | 4.94 x |
P/E ratio 2022 |
8.14
x | P/E ratio 2023 |
-5.46
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.53% |
1 week | -10.00% | ||
Current month | +1.98% | ||
1 month | +10.77% | ||
3 months | -20.00% | ||
6 months | -35.14% | ||
Current year | -20.53% |
Managers | Title | Age | Since |
---|---|---|---|
Mariola Söhngen
CEO | Chief Executive Officer | 63 | 20-09-14 |
Abdelghani Omari
DFI | Director of Finance/CFO | 48 | 22-08-31 |
Chairman | 71 | 93-12-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 93-12-09 | |
Roger McDowell
BRD | Director/Board Member | 69 | 14-06-30 |
Ursula Ney
BRD | Director/Board Member | 72 | 17-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.6 | 0.00% | 4 923 |
24-05-22 | 3.6 | -3.49% | 463,833 |
24-05-21 | 3.73 | +6.57% | 269,232 |
24-05-20 | 3.5 | -10.26% | 139,794 |
24-05-17 | 3.9 | -2.50% | 26,387 |
Delayed Quote London S.E., May 23, 2024 at 11:35 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.53% | 13.52M | |
-5.37% | 182B | |
-0.44% | 114B | |
-5.68% | 67.76B | |
+1.39% | 51.91B | |
+7.13% | 43.23B | |
+6.07% | 41.07B | |
+21.57% | 32.07B | |
+15.86% | 25B | |
-4.19% | 24.55B |
- Stock Market
- Equities
- PRM Stock